Compare CTVA & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTVA | CAH |
|---|---|---|
| Founded | 1802 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Other Pharmaceuticals |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 51.2B |
| IPO Year | 2018 | 1994 |
| Metric | CTVA | CAH |
|---|---|---|
| Price | $79.69 | $219.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | $80.13 | ★ $230.45 |
| AVG Volume (30 Days) | ★ 3.4M | 1.4M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.92% | ★ 0.95% |
| EPS Growth | 23.08 | ★ 86.96 |
| EPS | 1.60 | ★ 1.88 |
| Revenue | $17,401,000,000.00 | ★ $222,578,000,000.00 |
| Revenue This Year | $6.15 | $17.38 |
| Revenue Next Year | $3.15 | $9.00 |
| P/E Ratio | ★ $49.15 | $114.47 |
| Revenue Growth | ★ 2.92 | N/A |
| 52 Week Low | $53.40 | $120.72 |
| 52 Week High | $80.91 | $233.60 |
| Indicator | CTVA | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 63.12 | 49.74 |
| Support Level | $71.67 | $206.07 |
| Resistance Level | $80.91 | $231.90 |
| Average True Range (ATR) | 1.77 | 4.72 |
| MACD | -0.19 | -1.46 |
| Stochastic Oscillator | 80.40 | 32.02 |
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.